CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
The combination of silymarin and pegylated interferon alpha2b attenuates the progression of liver fibrosis in prior nonresponders and relapsers with chronic hepatitis C infection – the PROFI C trial
DOI 10.1055/s-2008-1037602
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Ocker, D Neureier, D Schuppan, C Herold
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: The aim of this investigation was to study the effect of maintenance pegylated interferon with and without Silymarin on fibrosis progression in patients with chronic Hepatitis C virus infection, who failed prior therapy. Material and Methods: In a prospective and randomized multi-center trial patients were treated for 24 months with a combination of pegylated interferon a2b (100µg/week or 50µg/every othe…
Zitieren
Zitierempfehlung
M Ocker, D Neureier, D Schuppan, C Herold (2008) The combination of silymarin and pegylated interferon alpha2b attenuates the progression of liver fibrosis in prior nonresponders and relapsers with chronic hepatitis C infection – the PROFI C trial. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-2008-1037602
Mit CareLit weiterarbeiten